Safety of pandemic H1N1 vaccines monitored by WHO
by Anil Kumar

WHO estimates that around 80 million doses of pandemic vaccine have been distributed and around 65 million people have been vaccinated. National immunization campaigns began in Australia and the People's Republic of China in late September.
Vaccination campaigns currently under way to protect populations from pandemic influenza are among the largest in the history of several countries, and numbers are growing daily.
Given this scale of vaccine administration, at least some rare adverse reactions, not detectable during even large clinical trials, could occur, underscoring the need for rigorous monitoring of safety. Results to date are encouraging.
As anticipated, side effects commonly reported include swelling, redness, or pain at the injection site, which usually resolves spontaneously a short time after vaccination.
Fever, headache, fatigue, and muscle aches, occurring shortly after vaccine administration, have also been reported, though with less frequency. These symptoms also resolve spontaneously, usually within 48 hours. In addition, a variety of allergic reactions has been observed. The frequency of these reactions is well within the expected range.
Guillain-Barre syndrome
To date, fewer than ten suspected cases of Guillain-Barre syndrome have been reported in people who have received vaccine. These numbers are in line with normal background rates of this illness, as reported in a recent study. Nonetheless, all such cases are being investigated to determine whether these are randomly occurring events or if they might be associated with vaccination.
WHO has received no reports of fatal outcomes among suspected or confirmed cases of Guillain-Barre syndrome detected since vaccination campaigns began. All cases have recovered. WHO recommends continued active monitoring for Guillain-Barre syndrome.
Investigations of deaths
A small number of deaths have occurred in people who have been vaccinated. All such deaths, reported to WHO, have been promptly investigated. Although some investigations are ongoing, results of completed investigations reported to WHO have ruled out a direct link to pandemic vaccine as the cause of death.
In China, for example, where more than 11 million doses of pandemic vaccine have been administered, health authorities have informed WHO of 15 cases of severe side effects and two deaths that occurred following vaccination. Thorough investigation of these deaths, including a review of autopsy results, determined that underlying medical conditions were the cause of death, and not the vaccine.
Safety profile of different vaccines
Campaigns are using nonadjuvanted inactivated vaccines, adjuvanted inactivated vaccines, and live attenuated vaccines. No differences in the safety profile of severe adverse events among different vaccines have been detected to date.
Although intense monitoring of vaccine safety continues, all data compiled to date indicate that pandemic vaccines match the excellent safety profile of seasonal influenza vaccines, which have been used for more than 60 years.
(Anil Kumar -- sub-editor compiled and published
Safety of pandemic H1N1 vaccines monitored by WHO at HealthNewsTrack on November 23, 2009 sourced from World Health Organization - http://www.who.int/)
Swine Flu - recent articles and current news stories:
-
Swine flu vaccine causing sudden sleep disorder narcolepsy in children-
Symptom patterns differ between pandemic, seasonal flu in Singapore-
Vaccinate against H1N1 Flu and Seasonal Flu-
Insect cells provide the key to alternative swine flu vaccination-
H1N1 influenza severity linked to Streptococcus pneumoniaeMost related articles:
-
Safety of pandemic H1N1 vaccines monitored by WHO-
H1N1 flu vaccine donations for developing world - 11.9
-
H1N1 flu vaccines to be used in 2010 influenza season - 10.5
-
WHO reviewed pandemic vaccine policies and strategies - 8.5
-
Americans would not take an H1N1 flu vaccine - 8.2
More related articles:
- Pandemic H1N1 vaccine, Pandemic vaccine, Immunization, Vaccination, Pandemic influenza, Vaccine, Swine influenza, Swine flu, H1N1 Flu, Influenza
-
H1N1 flu vaccines to be used in 2010 influenza season - 43.4
-
H1N1 flu vaccine donations for developing world - 39.9
-
Insect cells provide the key to alternative swine flu vaccination - 37.2
-
H1N1 vaccine Focetria receives positive opinion from CHMP - 34.3
-
H1N1 flu vaccine could control swine flu pandemic - 34.2
Swine Flu related articles:
-
Human Swine Influenza Investigation in US - 5.5
-
Swine flu cases decreasing in UK - 4.7
-
RPSGB warns against counterfeit drugs for swine flu - 4.5
-
Swine Flu update for people with heart disease - 4.4
-
Swine flu transmission to humans occurred months before outbreak - 4.3
Swine Flu article/news source:
Read more health articles from
World Health Organization and
health articles from Switzerland.
Swine Flu - search related terms:
H1N1 Flu,
Immunization,
Influenza,
Pandemic H1N1 vaccine,
Pandemic influenza,
Pandemic vaccine,
Swine flu,
Swine influenza,
Vaccination,
Vaccine,
Swine Flu books,
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.
Current news
Safety of pandemic vaccines -- Pandemic (H1N1) 2009 briefing note 16.
What is Swine Flu?About Swine Flu -- Swine influenza (Swine flu, H1N1 Flu, Influenza A H1N1) refers to influenza cases that are caused by Orthomyxoviruses endemic to populations of pigs. The viruses are referred to as Swine influenza virus (SIV). SIV strains isolated to date have been classified either as Influenza virus C or one of the various subtypes of the genus Influenza virus A.